Apellis Pharmaceuticals, Inc. (BIT:1APLS)
16.88
0.00 (0.00%)
At close: Aug 1, 2025, 5:30 PM CET
Paramount Global Market Cap
Apellis Pharmaceuticals has a market cap or net worth of €2.64 billion as of August 8, 2025. Its market cap has decreased by -36.90% in one year.
Market Cap
2.64B
Enterprise Value
2.72B
Revenue
642.58M
Ranking
n/a
PE Ratio
n/a
Stock Price
$16.88
Market Cap Chart
Since November 9, 2017, Apellis Pharmaceuticals's market cap has increased from 593.77M to 2.64B, an increase of 344.31%. That is a compound annual growth rate of 21.22%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 8, 2025 | 2.64B | -31.19% |
Dec 31, 2024 | 3.83B | -40.26% |
Dec 29, 2023 | 6.42B | 19.95% |
Dec 30, 2022 | 5.35B | 32.19% |
Dec 31, 2021 | 4.05B | 14.29% |
Dec 31, 2020 | 3.54B | 103.16% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Nov 9, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
UniCredit | 103.09B |
Intesa Sanpaolo | 93.48B |
Enel SpA | 78.77B |
Ferrari | 68.26B |
Assicurazioni Generali | 50.69B |
Eni S.p.A. | 45.13B |
Leonardo S.p.a. | 26.87B |
Poste Italiane | 25.59B |